Search Ontology:
ChEBI
13,14-dihydro-15-keto-PGF2alpha
- Term ID
- CHEBI:63976
- Synonyms
-
- (5Z,9alpha,11alpha)-9,11-dihydroxy-15-oxoprost-5-en-1-oic acid
- 13,14-Dihydro-15-keto-pgf2alpha
- 13,14-dihydro-15-keto-Prostaglandin F2a
- 13,14-Dihydro-15-ketoprostaglandin F2alpha
- 15-Keto-13,14-dihydro-pgf2alpha
- 15-Keto-13,14-dihydroprostaglandin F2-alpha
- 15-Keto-13,14-dihydroprostaglandin F2alpha
- 9S,11S-dihydroxy-15-oxo-5Z-prostenoic acid
- Dhk-pgf2alpha
- PGFM
- Definition
- A prostaglandin Falpha obtained by formal oxidation of the 15-hydroxy group and hydrogenation of the 13,14-double bond of prostaglandin F2alpha.
- References
-
- CAS:27376-76-7
- HMDB:HMDB0004685
- LIPID_MAPS_instance:LMFA03010027
- PMID:20961606
- PMID:21228218
- PMID:21615801
- PMID:21653895
- PMID:21741578
- PMID:21924479
- PMID:21940119
- PMID:22192399
- Patent:US5397797
- Reaxys:6227023
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_functional_parent
-
- has_role
-
- inverse has_functional_parent
-
- inverse is_conjugate_base_of
-
- is_conjugate_acid_of
-
Show first 5 Terms
Phenotype
Phenotype resulting from 13,14-dihydro-15-keto-PGF2alpha
Phenotype where environments contain 13,14-dihydro-15-keto-PGF2alpha
Phenotype modified by environments containing 13,14-dihydro-15-keto-PGF2alpha
Human Disease Model